NCT07782970: A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- State
- Under way
- Phase
- Phase 3
- People
- 218 planned
- Started
- 28 Sep 2026
- Primary completion
- 6 Mar 2029
- Arms
- Participants receiving GSK5784283 + standard of care (SoC)
- Results
- None posted
- 24 Aug 2026: Trial registered
- 28 Sep 2026: Trial started